Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis

被引:60
作者
Moser, B
Roth, G
Brunner, M
Lilaj, T
Deicher, R
Wolner, E
Kovarik, J
Boltz-Nitulescu, G
Vychytil, A
Ankersmit, HJ [1 ]
机构
[1] Gen Hosp Vienna, Dept Surg, Vienna, Austria
[2] Gen Hosp Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria
[3] Wilhelminenspital Stadt Wien, Klin Abt Nephrol, Vienna, Austria
[4] Gen Hosp Vienna, Dept Pathophysiol, Vienna, Austria
[5] Columbia Univ, New York, NY 10027 USA
关键词
apoptosis; chronic renal failure; haemodialysis; peritoneal dialysis; T cell activation; caspase; CD95; cell death; dialysis; ESRD;
D O I
10.1016/S0006-291X(03)01389-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Patients in end-stage renal disease (ESRD) have a high incidence of bacterial and viral infections. Fifteen non-dialysed (ND), 15 haemodialysed (HD), 15 patients with peritoneal dialysis (PD), and 15 healthy controls were included. T cell proliferation was measured by [H-3]thymidine uptake. Apoptosis and cell phenotype were determined by FACS. sTNF-R1, sCD95, interleukin-1beta-converting enzyme (sICE), and interleukin (IL)-10 were measured by ELISA. PHA and CD3-driven T cell proliferation were significantly decreased in ESRD patients. CD3(+), CD19(+) B cells, and percentage of CD4(+) T cells were significantly reduced. Percent memory T cells (CD45RO(+)) and cells undergoing apoptosis (CD95(+)/Annexin V+) were significantly increased in ESRF. Moreover, sCD95, sTNFRI, and ICE were significantly increased. Serum level of IL-10, a Th2 cytokine, was enhanced. These findings strongly suggest that in ESRD patients Th1 T cells are selectively susceptible to undergo apoptosis. This observation provides an additional pathophysiological concept in the genesis of Th2 dominance. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:581 / 585
页数:5
相关论文
共 26 条
[1]   Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device [J].
Ankersmit, HJ ;
Tugulea, S ;
Spanier, T ;
Weinberg, AD ;
Artrip, JH ;
Burke, EM ;
Flannery, M ;
Mancini, D ;
Rose, EA ;
Edwards, NM ;
Oz, MC ;
Itescu, S .
LANCET, 1999, 354 (9178) :550-555
[2]   Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy [J].
Ankersmit, HJ ;
Moser, B ;
Roedler, S ;
Teufel, I ;
Zuckermann, A ;
Roth, G ;
Lietz, K ;
Back, C ;
Gerlitz, S ;
Wolner, E ;
Boltz-Nitulescu, G .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 127 (01) :183-189
[3]   Impaired T cell proliferation, increased soluble death-inducing receptors and activation-induced T cell death in patients undergoing haemodialysis [J].
Ankersmit, HJ ;
Deicher, R ;
Moser, B ;
Teufel, I ;
Roth, G ;
Gerlitz, S ;
Itescu, S ;
Wolner, E ;
Boltz-Nitulescu, G ;
Kovarik, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (01) :142-148
[4]   PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[5]  
DESCAMPSLATSCHA B, 1993, KIDNEY INT, V43, pS135
[6]  
Fabrizi F, 1999, J NEPHROL, V12, P89
[7]  
George J., 1999, Human Antibodies, V9, P125
[8]   TETANUS IMMUNIZATION AND ITS ASSOCIATION TO HEPATITIS-B VACCINATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
GIRNDT, M ;
PIETSCH, M ;
KOHLER, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (03) :454-460
[9]  
GROOTEMAN MPC, 1995, NEPHROL DIAL TRANSPL, V10, P1859
[10]   Activation of interferon-gamma inducing factor mediated by interleukin-1 beta converting enzyme [J].
Gu, Y ;
Kuida, K ;
Tsutsui, H ;
Ku, G ;
Hsiao, K ;
Fleming, MA ;
Hayashi, N ;
Higashino, K ;
Okamura, H ;
Nakanishi, K ;
Kurimoto, M ;
Tanimoto, T ;
Flavell, RA ;
Sato, V ;
Harding, MW ;
Livingston, DJ ;
Su, MSS .
SCIENCE, 1997, 275 (5297) :206-209